The most common risk factors for post-HSCT thrombocytopenia are disease remission status, amount of infused CD34+ cells, graft-versus-host disease (GVHD), stem cell source, cytomegalovirus (CMV) infection, and drugs [4,5]. The gene discussed is CD34; the disease is graft versus host disease.